Chen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chen Wang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Andrew V. Kossenkov
The Wistar Institute, Philadelphia, Pennsylvania
2 shared publications - Benjamin G. Bitler
Department of OB/GYN, The University of Colorado Anschutz Medical Campus, Aurora, Colorado
2 shared publications - Dajiang Guo
Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology Prince of Wales Hospital, The Chinese University of Hong Kong Shatin Hong Kong
2 shared publications - Iris Müller
Cell Biology Program and Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, USA
2 shared publications - Jianhuang Lin
Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania
2 shared publications - Kristian Helin
Division of Cancer Biology, The Institute of Cancer Research
2 shared publications
Latest Publications
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Table S3 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
Table S3 shows the correlation between TRIM28 expression and clinical response to anti-PD1 therapy in melanoma based on a published proteomics database
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
Table S3 shows the correlation between TRIM28 expression and clinical response to anti-PD1 therapy in melanoma based on a published proteomics database
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figures S1-S5 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
Supplementary Figures S1-S5 + Legends
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigures S1-S5 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
Supplementary Figures S1-S5 + Legends
- Open Access
- 10 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1041533
Deficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS
Vascular leakage and inflammation are pathological hallmarks of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Endothelial cells (ECs) serve as a semipermeable barrier and play a key role in disease progression. It is well known that fibroblast growth factor receptor 1 (FGFR1) is required for maintaining vascular integrity. However, how endothelial FGFR1 functions in ALI/ARDS remains obscure. Here, we revealed that conditional deletion of endothelial FGFR1 aggravated LPS-induced lung injury, including inflammation and vascular leakage. Inhibition of its downstream Rho-associated coiled-coil–forming protein kinase 2 (ROCK2) by AAV Vec-tie-shROCK2 or its selective inhibitor TDI01 effectively attenuated inflammation and vascular leakage in a mouse model. In vitro, TNFα-stimulated human umbilical vein endothelial cells (HUVECs) showed decreased FGFR1 expression and increased ROCK2 activity. Furthermore, knockdown of FGFR1 activated ROCK2 and thus promoted higher adhesive properties to inflammatory cells and higher permeability in HUVECs. TDI01 effectively suppressed ROCK2 activity and rescued the endothelial dysfunction. These data demonstrated that the loss of endothelial FGFR1 signaling mediated an increase in ROCK2 activity, which led to an inflammatory response and vascular leakage in vivo and in vitro. Moreover, inhibition of ROCK2 activity by TDI01 provided great value and shed light on clinical translation.
- 10 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1041533
Open AccessDeficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS
Vascular leakage and inflammation are pathological hallmarks of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Endothelial cells (ECs) serve as a semipermeable barrier and play a key role in disease progression. It is well known that fibroblast growth factor receptor 1 (FGFR1) is required for maintaining vascular integrity. However, how endothelial FGFR1 functions in ALI/ARDS remains obscure. Here, we revealed that conditional deletion of endothelial FGFR1 aggravated LPS-induced lung injury, including inflammation and vascular leakage. Inhibition of its downstream Rho-associated coiled-coil–forming protein kinase 2 (ROCK2) by AAV Vec-tie-shROCK2 or its selective inhibitor TDI01 effectively attenuated inflammation and vascular leakage in a mouse model. In vitro, TNFα-stimulated human umbilical vein endothelial cells (HUVECs) showed decreased FGFR1 expression and increased ROCK2 activity. Furthermore, knockdown of FGFR1 activated ROCK2 and thus promoted higher adhesive properties to inflammatory cells and higher permeability in HUVECs. TDI01 effectively suppressed ROCK2 activity and rescued the endothelial dysfunction. These data demonstrated that the loss of endothelial FGFR1 signaling mediated an increase in ROCK2 activity, which led to an inflammatory response and vascular leakage in vivo and in vitro. Moreover, inhibition of ROCK2 activity by TDI01 provided great value and shed light on clinical translation.
- 8 April 2010
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 6 (6) , 954-957
Preparation and characterization of lectin-conjugated chitosan fluorescent nanoparticles
The purpose of this study was to design and evaluate a novel target nanoparticle for disease detection and drug delivery using the biotin–avidin binding system. The formed lectin-conjugated chitosan fluorescent nanoparticles were of spherical shape (100–200 nm in diameter), which were more stable under light than pure fluorescein isothiocyanate (FITC).
- 8 April 2010
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 6 (6) , 954-957
Preparation and characterization of lectin-conjugated chitosan fluorescent nanoparticles
The purpose of this study was to design and evaluate a novel target nanoparticle for disease detection and drug delivery using the biotin–avidin binding system. The formed lectin-conjugated chitosan fluorescent nanoparticles were of spherical shape (100–200 nm in diameter), which were more stable under light than pure fluorescein isothiocyanate (FITC).
- 2 December 2005
- Published by Springer Nature
- p. 355-357
Prediction of protein transmembrane segments using a hydrophobicity scale derived from hydrophobic peptides
- 2 December 2005
- Published by Springer Nature
- p. 355-357
Prediction of protein transmembrane segments using a hydrophobicity scale derived from hydrophobic peptides